Cited by 133Viral Infections and Immunology ResearchCardiac Fibrosis and Remodelinginterferon and immune responses

IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart

Fairweather, DeLisa, Frisancho-Kiss, Sylvia, Yusung, Susy A, Barrett, Masheka A, Davis, Sarah E, Steele, Ronelle A, Gatewood, Shannon J L, Rose, Noel R·2005·The Journal of Immunology

Abstract

Th1-type immune responses, mediated by IL-12-induced IFN-gamma, are believed to exacerbate certain autoimmune diseases. We recently found that signaling via IL-12Rbeta1 increases coxsackievirus B3 (CVB3)-induced myocarditis. In this study, we examined the role of IL-12 on the development of CVB3-induced myocarditis using mice deficient in IL-12p35 that lack IL-12p70. We found that IL-12 deficiency did not prevent myocarditis, but viral replication was significantly increased. Although there were no changes in the total percentage of inflammatory cells in IL-12-deficient hearts compared with wild-type BALB/c controls by FACS analysis, macrophage and neutrophil populations were decreased. This decrease corresponded to reduced TNF-alpha and IFN-gamma levels in the heart, suggesting that macrophage and/or neutrophil populations may be a primary source of TNF-alpha and IFN-gamma during acute CVB3 myocarditis. Increased viral replication in IL-12-deficient mice was not mediated by reduced TNFRp55 signaling, because viral replication was unaltered in TNFRp55-deficient mice. However, STAT4 or IFN-gamma deficiency resulted in significantly increased viral replication and significantly reduced TNF-alpha and IFN-gamma levels in the heart, similar to IL-12 deficiency, indicating that the IL-12/STAT4 pathway of IFN-gamma production is important in limiting CVB3 replication. Furthermore, STAT4 or IFN-gamma deficiency also increased chronic CVB3 myocarditis, indicating that therapeutic stra…

Integrity signals

Registry

Crossref · 10.4049/jimmunol.174.1.261

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IFNs reduce viral replication and prevent remodeling and fibrosis and thereby progression to DCM.

    “However, IFNs reduce viral replication and prevent remodeling and fibrosis and thereby progression to DCM. 128,169,170”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [169]

  • Type I and II IFNs are a dominant immune response in CVB3 myocarditis models and EAM, where inhibition of these pathways leads to increased viral replication, pericardial and myocardial inflammation, and DCM.

    “Type I and II IFNs are a dominant immune response in CVB3 myocarditis models (and EAM) where inhibition of these pathways leads to increased viral replication, pericardial and myocardial inflammation, and DCM. 124,128,152,169,170”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [169]

The citation lists haven’t been fetched yet

References 76 · Cited by 133

Authors
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R.
Affiliations
  • Johns Hopkins University (US)
  • Department of Pathology, Johns Hopkins Medical Institutions , Baltimore, MD 21205
Corresponding author
Fairweather, DeLisa
Venue
The Journal of Immunology
Published
2005-01-01
Volume
174
Issue
1
Pages
261-269
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1591647807
Cited by
133
References
76
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 10 · 2012: 10
FWCI
6.40
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL 67290, R01HL067290, HL 70729, R01HL070729)
  • National Institute of Allergy and Infectious Diseases (AI 51835, R21AI051835)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
IL-12, coxsackievirus B3, viral myocarditis, interferon-gamma, STAT4, Th1 response, macrophages, neutrophils, TNF-α, viral replication, chronic myocarditis, cardiac inflammation
MeSH terms
Animals, Coxsackievirus Infections, DNA-Binding Proteins, Flow Cytometry, Interferon-gamma, Macrophages, Myocarditis, Neutrophils, Tumor Necrosis Factor-alpha, Trans-Activators, Interleukin-12, Protein Subunits, Enterovirus B, Human, Receptors, Tumor Necrosis Factor, Type I, STAT4 Transcription Factor, Mice, Interleukin-12 Subunit p35

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review